76282-0709 Lanreotide Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

76282-0709

Brand Name:

Lanreotide Acetate

Generic Name:

Lanreotide acetate

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: LANREOTIDE ACETATE

Strength: 60.0

Unit: mg/.2mL

Packages:

Code: 76282-0709-67

Description: 1 SYRINGE in 1 CARTON (76282-709-67) / .2 mL in 1 SYRINGE

Effective Date: June 1, 2022

Discontinued: Aug. 18, 2023

SEER*Rx Category:

Hormonal Therapy

Major Class:

Somatostatin Analog

Minor Class:

Orphan Drug Designation:

Status:

In Use